Edition:
United States

Boiron SA (BOIR.PA)

BOIR.PA on Paris Stock Exchange

73.26EUR
15 Dec 2017
Change (% chg)

€-0.74 (-1.00%)
Prev Close
€74.00
Open
€74.09
Day's High
€74.09
Day's Low
€72.78
Volume
11,629
Avg. Vol
5,104
52-wk High
€92.70
52-wk Low
€72.78

Chart for

About

Boiron SA is a France-based pharmaceutical company engaged in the provision of homeopathic medicines. The Company develops, manufactures and markets single homeopathic medicines and drugs which are in the form of tablets, syrups, single-dose liquids and ointments. It also produces medicines based on trace elements, phytotherapy... (more)

Overall

Beta: 0.91
Market Cap(Mil.): €1,422.32
Shares Outstanding(Mil.): 19.41
Dividend: 1.60
Yield (%): 2.18

Financials

  Industry Sector
P/E (TTM): -- 32.20 16.04
EPS (TTM): -- -- --
ROI: -- 15.06 34.69
ROE: -- 16.55 15.46

French and Benelux stocks-Factors to watch on Dec 15

Dec 15 Below are company-related news and stories from French and Benelux media which could have an impact on the region's markets or individual stocks.

Dec 15 2017

BRIEF-Boiron Q3 revenue increases to 163.9‍​ million euros

* Q3 REVENUE EUR 163.9‍​ MILLION VERSUS EUR 159.4 MILLION YEAR AGO

Oct 19 2017

BRIEF-Boiron H1 operating result down 5.4 pct to ‍​41.1 million euros

* H1 OPERATING RESULT EUR ‍​41.1 MILLION VERSUS EUR 43.4 MILLION YEAR AGO

Sep 07 2017

Earnings vs. Estimates